Location: Vienna, Austria
Date: February 12 to February 15
Transmural healing in IBD
Prof Ghosh illustrated the importance of transmural healing in inflammatory bowel disease management.
A Next-Generation, Dual-Action Anti-Integrin Therapy for IBD
Prof. Rubin speaks about the newer anti‑integrin therapies, like etrolizumab.
How to sequence advanced therapies in IBD
Prof. Schreiber speaks about evidence from clinical trials and real-world experience.